Hong Kong
· Delayed Price · Currency is HKD WuXi Biologics Company Description
WuXi Biologics (Cayman) Inc., an investment holding company, provides end-to-end solutions and services for biologics discovery, development, and manufacturing for biologics industry in the People’s Republic of China, North America, Europe, Singapore, Japan, South Korea, and Australia.
It operates through two segments: Biologics and XDC. The company provides a suite of solutions for biologic discovery, from concept to IND, that seamlessly transits to CMC and downstream process development through its contract research, development, and manufacturing organization platforms, including WuXiBody, SDArBodY, T cell engager, Single B Cell Cloning Technology, WuXia, WuXiUP, WuXiUI, and WuXiHigh.
It also engages in the provision of consultation services in relation to the biopharmaceutical technology, international sales contracting services, testing and development of testing technologies, sales and marketing services, production and sales of medicals, and biologics clinical and manufacturing services; production and sale of medicals; vaccine contract development and manufacturing organization (CDMO) and related business; and engages in investment and material supplier activities.
The company has a research service agreement with BioNTech SE to discover and investigate monoclonal antibodies for developing next-generation therapeutic product candidates.
The company was incorporated in 2014 and is headquartered in Wuxi, China.
| Country | Cayman Islands |
| Founded | 2014 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 12,740 |
| CEO | Zhisheng Chen |
Contact Details
Address: No. 108, Meiliang Road Wuxi, 214092 China | |
| Website | wuxibiologics.com |
Stock Details
| Ticker Symbol | 2269 |
| Exchange | Hong Kong Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | KYG970081173 |
| SIC Code | 8731 |
Key Executives
| Name | Position |
|---|---|
| Dr. Weichang Zhou Ph.D. | Honorary President of Global Biologics Development, Senior Advisor to Chief Executive Officer and Non-Executive Director |
| Dr. Zhisheng Chen Ph.D. | Chief Executive Officer and Executive Director |
| Dr. Ge Li Ph.D. | Founder and Chairman |
| Ming Tu | Chief Financial Officer and Executive Vice President |
| Lihua Yu M.B.A. | Chief Operating Officer and Senior Vice President |
| Dr. Sherry Gu Ph.D. | Chief Technology Officer and Executive Vice President of Global Biologics Development Department |
| Dr. Jijie Gu Ph.D. | Chief Scientific Officer and President of Global Biologics Research |
| Lina Fan Ph.D. | Senior Vice President and Head of Investor Relations |
| He Wang | Chief Compliance Officer, Senior Vice President and Head of Global Compliance and Risk Management |
| Li Xiong | Vice President and Head of Global Human Resources |